JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

159 hedge funds and large institutions have $1.27B invested in Juno Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 43 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$18.7M
Puts
$27M
Net Calls
Net Calls Change

Top Buyers

1 +$33.5M
2 +$14.8M
3 +$9.01M
4
BB
BB Biotech
Switzerland
+$8.77M
5
Ameriprise
Ameriprise
Minnesota
+$6.77M

Top Sellers

1 -$23.9M
2 -$18.9M
3 -$14.8M
4
BAMCO Inc
BAMCO Inc
New York
-$13.3M
5
CCI
Columbus Circle Investors
-$4.22M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$327M
2
$209M
3
$110M
4
$64.4M
5
$41M
6
$40.9M
7
$40.5M
8
$36.2M
9
$35.3M
10
$34.5M
11
$33.5M
12
$23.2M
13
$18.1M
14
$17.9M
15
$17.7M
16
$17.3M
17
$15.3M
18
$14.9M
19
$14M
20
$10.3M
21
$8.19M
22
$6.77M
23
$6.36M
24
$5.31M
25
$5.08M